Engineering brain organoids to improve their structure and function
Patterning human forebrain organoids by engineering controlled biochemical microenvironment
['FUNDING_R21'] · UNIVERSITY OF MASSACHUSETTS AMHERST · NIH-10671748
This study is working on improving tiny brain models to help us learn more about how the brain develops and what goes wrong in brain disorders, which could lead to better treatments for patients like you.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MASSACHUSETTS AMHERST (nih funded) |
| Locations | 1 site (HADLEY, UNITED STATES) |
| Trial ID | NIH-10671748 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing human brain organoids, which are miniaturized versions of the brain, to better understand brain development and neurological disorders. By creating controlled biochemical environments using innovative microdevices, the researchers aim to improve the reproducibility and accuracy of these organoids. This approach involves developing devices that generate specific concentration gradients of signaling molecules, which are crucial for proper brain patterning. Patients may benefit from the insights gained into brain disorders and potential new therapies that could arise from this work.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by neurological disorders or those interested in advancements in brain-related therapies.
Not a fit: Patients with conditions unrelated to brain development or neurological disorders may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for neurological disorders by improving our understanding of brain development and function.
How similar studies have performed: Other research has shown promise in using engineered organoids for studying brain disorders, indicating that this approach could lead to significant advancements.
Where this research is happening
HADLEY, UNITED STATES
- UNIVERSITY OF MASSACHUSETTS AMHERST — HADLEY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SUN, YUBING — UNIVERSITY OF MASSACHUSETTS AMHERST
- Study coordinator: SUN, YUBING
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.